Information Journal Paper
APA:
Copy. (2017). A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo. LEUKEMIA, 31(-), 1743-1751. SID. https://sid.ir/paper/740655/en
Vancouver:
Copy. A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo. LEUKEMIA[Internet]. 2017;31(-):1743-1751. Available from: https://sid.ir/paper/740655/en
IEEE:
Copy, “A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo,” LEUKEMIA, vol. 31, no. -, pp. 1743–1751, 2017, [Online]. Available: https://sid.ir/paper/740655/en